Cargando…

Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity

Metastasis is the main cause of cancer-related mortality; therefore, the ability to predict its propensity can remarkably affect survival rate. Metastasis development is predicted nowadays by lymph-node status, tumor size, histopathology, and genetic testing. However, all these methods may have inac...

Descripción completa

Detalles Bibliográficos
Autores principales: Merkher, Yulia, Kontareva, Elizaveta, Bogdan, Elizaveta, Achkasov, Konstantin, Maximova, Ksenia, Grolman, Joshua M., Leonov, Sergey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387085/
https://www.ncbi.nlm.nih.gov/pubmed/37516753
http://dx.doi.org/10.1038/s41598-023-33540-1
_version_ 1785081810307252224
author Merkher, Yulia
Kontareva, Elizaveta
Bogdan, Elizaveta
Achkasov, Konstantin
Maximova, Ksenia
Grolman, Joshua M.
Leonov, Sergey
author_facet Merkher, Yulia
Kontareva, Elizaveta
Bogdan, Elizaveta
Achkasov, Konstantin
Maximova, Ksenia
Grolman, Joshua M.
Leonov, Sergey
author_sort Merkher, Yulia
collection PubMed
description Metastasis is the main cause of cancer-related mortality; therefore, the ability to predict its propensity can remarkably affect survival rate. Metastasis development is predicted nowadays by lymph-node status, tumor size, histopathology, and genetic testing. However, all these methods may have inaccuracies, and some require weeks to complete. Identifying novel prognostic markers will open an essential source for risk prediction, possibly guiding to elevated patient treatment by personalized strategies. Cancer cell invasion is a critical step in metastasis. The cytoskeletal mechanisms used by metastatic cells for the invasion process are very similar to the utilization of actin cytoskeleton in the endocytosis process. In the current study, the adhesion and encapsulation efficiency of low-cost carboxylate-modified fluorescent nanoparticles by breast cancer cells with high (HM) and low metastatic potential (LM) have been evaluated; benign cells were used as control. Using high-content fluorescence imaging and analysis, we have revealed (within a short time of 1 h), that efficiency of nanoparticles adherence and encapsulation is sufficiently higher in HM cells compared to LM cells, while benign cells are not encapsulating or adhering the particles during experiment time at all. We have utilized custom-made automatic image analysis algorithms to find quantitative co-localization (Pearson’s coefficients) of the nanoparticles with the imaged cells. The method proposed here is straightforward; it does not require especial equipment or expensive materials nor complicated cell manipulations, it may be potentially applicable for various cells, including patient-derived cells. Effortless and quantitative determination of the metastatic likelihood has the potential to be performed using patient-specific biopsy/surgery sample, which will directly influence the choice of protocols for cancer patient’s treatment and, as a result, increase their life expectancy.
format Online
Article
Text
id pubmed-10387085
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103870852023-07-31 Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity Merkher, Yulia Kontareva, Elizaveta Bogdan, Elizaveta Achkasov, Konstantin Maximova, Ksenia Grolman, Joshua M. Leonov, Sergey Sci Rep Article Metastasis is the main cause of cancer-related mortality; therefore, the ability to predict its propensity can remarkably affect survival rate. Metastasis development is predicted nowadays by lymph-node status, tumor size, histopathology, and genetic testing. However, all these methods may have inaccuracies, and some require weeks to complete. Identifying novel prognostic markers will open an essential source for risk prediction, possibly guiding to elevated patient treatment by personalized strategies. Cancer cell invasion is a critical step in metastasis. The cytoskeletal mechanisms used by metastatic cells for the invasion process are very similar to the utilization of actin cytoskeleton in the endocytosis process. In the current study, the adhesion and encapsulation efficiency of low-cost carboxylate-modified fluorescent nanoparticles by breast cancer cells with high (HM) and low metastatic potential (LM) have been evaluated; benign cells were used as control. Using high-content fluorescence imaging and analysis, we have revealed (within a short time of 1 h), that efficiency of nanoparticles adherence and encapsulation is sufficiently higher in HM cells compared to LM cells, while benign cells are not encapsulating or adhering the particles during experiment time at all. We have utilized custom-made automatic image analysis algorithms to find quantitative co-localization (Pearson’s coefficients) of the nanoparticles with the imaged cells. The method proposed here is straightforward; it does not require especial equipment or expensive materials nor complicated cell manipulations, it may be potentially applicable for various cells, including patient-derived cells. Effortless and quantitative determination of the metastatic likelihood has the potential to be performed using patient-specific biopsy/surgery sample, which will directly influence the choice of protocols for cancer patient’s treatment and, as a result, increase their life expectancy. Nature Publishing Group UK 2023-07-29 /pmc/articles/PMC10387085/ /pubmed/37516753 http://dx.doi.org/10.1038/s41598-023-33540-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Merkher, Yulia
Kontareva, Elizaveta
Bogdan, Elizaveta
Achkasov, Konstantin
Maximova, Ksenia
Grolman, Joshua M.
Leonov, Sergey
Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity
title Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity
title_full Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity
title_fullStr Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity
title_full_unstemmed Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity
title_short Encapsulation and adhesion of nanoparticles as a potential biomarker for TNBC cells metastatic propensity
title_sort encapsulation and adhesion of nanoparticles as a potential biomarker for tnbc cells metastatic propensity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387085/
https://www.ncbi.nlm.nih.gov/pubmed/37516753
http://dx.doi.org/10.1038/s41598-023-33540-1
work_keys_str_mv AT merkheryulia encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity
AT kontarevaelizaveta encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity
AT bogdanelizaveta encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity
AT achkasovkonstantin encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity
AT maximovaksenia encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity
AT grolmanjoshuam encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity
AT leonovsergey encapsulationandadhesionofnanoparticlesasapotentialbiomarkerfortnbccellsmetastaticpropensity